Page last updated: 2024-11-12

aculeatin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aculeatin A: antineoplastic from Amomum aculeatum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AmomumgenusA plant genus of the family ZINGIBERACEAE. Members contain aculeatin D, beta-sitosterol, and STIGMASTEROL. Some members have been reclassified to ELETTARIA and other ZINGIBERACEAE.[MeSH]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID10409797
CHEMBL ID428425
MeSH IDM0452469

Synonyms (5)

Synonym
CHEMBL428425
aculeatins a
(+)-aculeatine d
aculeatin a
(2r,4r,6r)-2-hydroxy-4-tridecyl-5,7-dioxadispiro[5.1.58.26]pentadeca-9,12-dien-11-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID329575Cytotoxicity against human MCF7 cells2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID362707Cytotoxicity against human K562 cells assessed as radioactive thymidine incorporation after 24 hrs2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
AID422146Growth inhibition of human MCF7 cells xenografted in NCr nu/nu mouse at 6.25 to 50 mg/kg, ip once daily administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test2009Journal of natural products, Mar-27, Volume: 72, Issue:3
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
AID1873087Antimalarial activity against chloroquine and pyrimethamine resistant Plasmodium falciparum K1 infected in human red blood cells assessed as inhibition of parasite growth incubated for 72 hrs by [3H]-hypoxanthine incorporation assay based liquid scintilla2022European journal of medicinal chemistry, Jul-05, Volume: 237Spiral molecules with antimalarial activities: A review.
AID362469Antimalarial activity against Plasmodium falciparum 3D7 in human erythrocytes after 48hrs by [3H]hypoxanthine uptake2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
AID424510Growth inhibition of human MCF7 cells xenografted in NCr nu/nu mouse at 6.25 to 50 mg/kg, sc once daily administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test2009Journal of natural products, Mar-27, Volume: 72, Issue:3
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
AID329583Antitumor activity against human A2780S cells xenografted in mouse at 3 mg/kg relative to control2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID362472Selectivity index, ratio of CC50 for human K562 cells to IC50 for Plasmodium falciparum 3D72008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
AID329577Inhibition of human Lu1 cells propagated in hollow fibers via intraperitoneal site of immunodeficient mouse at 6.25 to 50 mg/kg after 3 to 6 days2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID1873088Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in human red blood cells assessed as inhibition of parasite growth incubated for 72 hrs by [3H]-hypoxanthine incorporation assay based liquid scintillation counter met2022European journal of medicinal chemistry, Jul-05, Volume: 237Spiral molecules with antimalarial activities: A review.
AID329576Inhibition of human MCF7 cells propagated in hollow fibers via intraperitoneal site of immunodeficient mouse at 6.25 to 50 mg/kg after 3 to 6 days2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID329581Inhibition of human LNCaP cells propagated in hollow fibers via subcutaneous site of immunodeficient mouse at 6.25 to 50 mg/kg after 3 to 6 days2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID329578Inhibition of human LNCaP cells propagated in hollow fibers via intraperitoneal site of immunodeficient mouse at 6.25 to 50 mg/kg after 3 to 6 days2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID329582Antitumor activity against mouse P388 lymphocytic leukemia model at 15 mg/kg, ip relative to control2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID400915Cytotoxicity against Myosarcoma cells2004Journal of natural products, Apr, Volume: 67, Issue:4
New chromanone acids with antibacterial activity from Calophyllum brasiliense.
AID362470Antitoxoplasmal activity against Toxoplasma gondii RH-beta1 in HFF cells assessed as beta-galactosidase activity after 48 to 72 hrs by colorimetric microtiter assay2008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
AID329580Inhibition of human Lu1 cells propagated in hollow fibers via subcutaneous site of immunodeficient mouse at 6.25 to 50 mg/kg after 3 to 6 days2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID362474Antimalarial activity against Plasmodium falciparum K12008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
AID329574Cytotoxicity against human LNCaP cells2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID329579Inhibition of human MCF7 cells propagated in hollow fibers via subcutaneous site of immunodeficient mouse at 6.25 to 50 mg/kg after 3 to 6 days2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID329573Cytotoxicity against human Lu1 cells2008Journal of natural products, Mar, Volume: 71, Issue:3
Potential anticancer activity of naturally occurring and semisynthetic derivatives of aculeatins A and B from Amomum aculeatum.
AID362473Selectivity index, ratio of CC50 for human K562 cells to IC50 for Toxoplasma gondii RH-beta12008Journal of medicinal chemistry, Aug-28, Volume: 51, Issue:16
Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]